Ovarian cancer is one of the leading causes of tumor related deaths in women and it has the highest mortality rate among gynecological cancer diseases. The reason why this type of cancer is among the deadliest ones is due to the fact that the absence of specific symptoms leads to a delay in diagnosis. Moreover, ovarian cancer diagnosis is often performed with sonography (ultrasound, US), which is considered the gold standard examination, but shows high user-dependance. Finding a way to get an early diagnosis is fundamental to drastically reduce mortality. According to the international guidelines adopted by the medical community, the presence of papillary projections within ovarian cysts is a discriminant feature between benign and malignant conditions.